D. Paraïso

1.0k citations

35 papers · 689 indexed · h-index 14

Impact in

Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments

Papers in

Reproductive Medicine 19
- Ovarian cancer diagnosis and treatment 19
Obstetrics and Gynecology 9
- Endometrial and Cervical Cancer Treatments 9

Co-authors: Éric Pujade-Lauraine B. Weber Hubert Orfeuvre Anne‐Claire Hardy‐Bessard Bernard Leduc Hugues Bourgeois R. Largillier M. Combe
Journals: Journal of Clinical Oncology (11 papers)Annals of Oncology (4 papers)International Journal of Gynecological Cancer (3 papers)Gynecologic Oncology (3 papers)British Journal of Cancer (2 papers)
Partner nations: France Republic of the Congo Luxembourg

In The Last Decade

D. Paraïso

35 papers receiving 668 citations

Peers

Countries citing papers authored by D. Paraïso

Since Specialization

Citations

This map shows the geographic impact of D. Paraïso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Paraïso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Paraïso more than expected).

Fields of papers citing papers by D. Paraïso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Paraïso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Paraïso. The network helps show where D. Paraïso may publish in the future.

Co-authorship network

The 25 scholars most cited alongside D. Paraïso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Paraïso Line = papers co-authored together D. Paraïso links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO British Journal of Cancer ·Isabelle Ray‐Coquard, Laure Favier, B. Weber, C. Roemer-Bécuwe, Philippe Bougnoux, Michel Fabbro, Anne Floquet, Florence Joly, A. Plantade, D. Paraïso, Éric Pujade-Lauraine	2013	73
2	Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: Final results of the DOGMES multicentre GINECO trial European Journal of Cancer ·Claire Falandry, Étienne Brain, Marc Bonnefoy, F. Mefti, Nicolas Jovenin, Olivier Rigal, P Aldebert, Claude El Kouri, L. Uwer, Sophie Abadie‐Lacourtoisie, J Crétin, J.P. Jacquin, D. Paraïso, Gilles Freyer	2013	28
3	A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer Breast Cancer Research and Treatment ·Alain Lortholary, Anne‐Claire Hardy‐Bessard, Thomas Bachelot, Gaëtan De Rauglaudre, Jérôme Alexandre, Hugues Bourgeois, D Jaubert, D. Paraïso, Rémy Largillier	2011	4
4	Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens (GINECO) Annals of Oncology ·Alain Lortholary, R. Largillier, B. Weber, Laurence Gladieff, J. Alexandre, Xavier Durando, Zhiqiang Zhang, Jérôme Dauba, D. Paraïso, Éric Pujade-Lauraine	2011	71
5	Phase I study of irinotecan and cisplatin in combination with pelvic radiotherapy in the treatment of locally advanced cervical cancer: A GINECO trial Gynecologic Oncology ·Michel Fabbro, Laurence Gladieff, F. Guichard, 秦鹏秦鹏, Florence Dalenc, Christine Kerr, M. Delannes, D. Paraïso, Éric Pujade-Lauraine, Jean‐Emmanuel Kurtz	2010	9
6	Management of rare ovarian cancers: The experience of the French website «Observatory for rare malignant tumours of the ovaries» by the GINECO group: Interim analysis of the first 100 patients Gynecologic Oncology ·Isabelle Ray‐Coquard, B. Weber, Jean Pierre Lotz, Christophe Tournigand, Nilesh Juke, Didier Mayeur, Isabelle Treilleux, D. Paraïso, Pierre Duvillard, Éric Pujade-Lauraine	2010	25
7	Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLE Annals of Oncology ·Christelle de la Fouchardière, R. Largillier, Hosam Glal Eldein, Anne‐Claire Hardy‐Bessard, Borhane Slama, J Crétin, Hubert Orfeuvre, D. Paraïso, Thomas Bachelot, Éric Pujade-Lauraine	2009	10
8	Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial Gynecologic Oncology ·J.E. Kurtz, Anne‐Claire Hardy‐Bessard, Marion Deslandres, Sandrine Lavau‐Denès, R. Largillier, C. Roemer-Bécuwe, B. Weber, Cécile Guillemet, D. Paraïso, Éric Pujade-Lauraine	2009	62
9	Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group British Journal of Cancer ·(unknown), Isabelle Ray‐Coquard, B. Weber, J Crétin, I. Fenyő, E. Lévy, Anne‐Claire Hardy‐Bessard, M.C. Gouttebel, Pam De, 梁嘉, Hubert Orfeuvre, 周录平, J. Provençal, Jean-Marc Ferrero, 三浦裕次, Nadine Dohollou, D. Paraïso, J Salvat, Éric Pujade-Lauraine	2009	20
10	Treatment of FIGO stage IV ovarian carcinoma: results of primary surgery or interval surgery after neoadjuvant chemotherapy: a retrospective study International Journal of Gynecological Cancer ·Arash Rafii, Bruno Deval, J.-F. Geay, Nicolás Chopin, Xavier Paolettí, D. Paraïso, Éric Pujade-Lauraine	2007	30
11	HER2 overexpression and amplification in advanced ovarian cancer (AOC): Treatment with trastuzumab—A GINECO study Journal of Clinical Oncology ·Jean‐Paul Guastalla, Djelila Allouache, M. Combe, B. Weber, J Crétin, H. Curé, M Mousseau, D. Paraïso, Sarah Beckett Ference, Éric Pujade-Lauraine	2007	6
12	Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial Annals of Oncology ·Jean-Marc Ferrero, B. Weber, J.-F. Geay, D. Lepillé, Hubert Orfeuvre, M. Combe, F. Mayer, Bernard Leduc, Hugues Bourgeois, D. Paraïso, Éric Pujade-Lauraine	2006	86
13	Phase I study of pegylated liposomal doxorubicin (CA) and docetaxel (T) bimonthly in the first-line treatment of metastatic breast cancer (MBC): The CAT regimen Journal of Clinical Oncology ·Jean‐Paul Guastalla, Anne‐Claire Hardy‐Bessard, J.-F. Geay, H. Curé, Isabelle Ray‐Coquard, D. Paraïso, Éric Pujade-Lauraine	2004	1
14	A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study Cancer Chemotherapy and Pharmacology ·Maia Chandler, Jean Paul Guastalla, Jean Marc Ferrero, Timothy Boe, Neda Shamizi, Mike Gorman, Alain Lortholary, F. Mayer, D. Paraïso, E. Magherini, Éric Pujade-Lauraine	2004	11
15	Phase I study of pegylated liposomal doxorubicin (CA) and docetaxel (T) bimonthly in the first-line treatment of metastatic breast cancer (MBC): The CAT regimen Journal of Clinical Oncology ·Jean‐Paul Guastalla, Anne‐Claire Hardy‐Bessard, J.-F. Geay, H. Curé, Isabelle Ray‐Coquard, D. Paraïso, Éric Pujade-Lauraine	2004	3
16	Phase III randomized trial of high-dose chemotherapy (HDC) and peripheral blood stem cell (PBSC) support as consolidation in patients (pts) with advanced ovarian cancer (AOC): 5-year follow-up of a GINECO/FNCLCC/SFGM-TC study Journal of Clinical Oncology ·MA Yuan-yuan, Claudia Battista, Jean‐Paul Guastalla, Michel Fabbro, N. Tubiana-Mathieu, Hugues Bourgeois, Bruno Lioure, Bruno Chiurazzi, D. Paraïso, Éric Pujade-Lauraine	2004	32
17	HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group Annals of Oncology ·Sophie Camilleri‐Broët, Anne‐Claire Hardy‐Bessard, A. Le Tourneau, D. Paraïso, Olivier Levrel, Bernard Leduc, Stacey Bain, Hubert Orfeuvre, Josée Audouin, Éric Pujade-Lauraine	2003	80
18	High dose chemotherapy in ovarian cancer International Journal of Gynecological Cancer ·Éric Pujade-Lauraine, H. Curé, Zack Donohew, Jean‐Paul Guastalla, Bruno Chiurazzi, Michel Fabbro, N. Tubiana-Mathieu, Hugues Bourgeois, Bruno Lioure, D. Paraïso, Jean‐Pierre Lotz	2001	12
19	Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma Melanoma Research ·Olivier Rixe, Christian Borel, D. Paraïso, A. Benhammouda, Thierry Petit, Éric-Charles Antoine, J. P. Bizzari, G Auclerc, C. Soubrane, M Weil, B. Giroux, Pierre Banzet, D. Khayat	1995	10
20	Calcifications of the Breast Probably Due to Loa Loa American Journal of Tropical Medicine and Hygiene ·Bernard Carme, D. Paraïso, Е.В. Володина	1990	14

About D. Paraïso

D. Paraïso is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Radiology, Nuclear Medicine and Imaging and Geriatrics and Gerontology, having authored 35 papers that have together received 689 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (19 papers), Cancer Treatment and Pharmacology (11 papers), Endometrial and Cervical Cancer Treatments (9 papers), Intraperitoneal and Appendiceal Malignancies (8 papers), HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Advanced Biosensing Techniques and Applications (2 papers). The work is most often cited by research in Reproductive Medicine (401 citations), Obstetrics and Gynecology (203 citations), Oncology (272 citations), Surgery (216 citations) and Pathology and Forensic Medicine (78 citations). D. Paraïso has collaborated with scholars based in France, Republic of the Congo and Luxembourg. Frequent co-authors include Éric Pujade-Lauraine, B. Weber, Hubert Orfeuvre, Anne‐Claire Hardy‐Bessard, Bernard Leduc, Hugues Bourgeois, R. Largillier, M. Combe, C. Roemer-Bécuwe and Isabelle Ray‐Coquard. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, International Journal of Gynecological Cancer, Gynecologic Oncology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact